Trump Administration Moves to End Federal Medicaid Funding for Certain Gender Transition-Related Care for Minors

Dragon Media News Desk

US President Donald Trump’s administration has moved to end the use of federal Medicaid and Children’s Health Insurance Program funding for certain gender transition-related medical treatments for minors.

Under the new policy, federal health programme funding would no longer be available for certain surgeries, hormone treatments and puberty blockers provided to minors.

President Trump defended the decision in a social media post, saying the federal government should not pay for medical procedures that, in his view, could cause long-term or irreversible effects on children’s bodies.

The Trump administration has presented the policy as part of broader efforts to protect children’s health, address concerns over the long-term consequences of such medical interventions and ensure what it considers the appropriate use of federal healthcare funds.

The measure does not amount to a nationwide prohibition on such treatments across the United States. Its primary effect is on access to federal funding through public health insurance programmes.

Medical care related to gender transition for minors has remained the subject of significant political, legal and medical debate in the United States. Laws and regulations governing such treatment vary considerably from state to state.

The Trump administration has questioned the strength of long-term evidence supporting some of these interventions and has raised concerns about potential health risks.

Some medical organisations and rights groups, however, argue that treatment decisions should be made through consultation among patients, parents or guardians, and qualified medical professionals.

The federal policy is expected to have its greatest impact on families that rely on Medicaid and other publicly funded health insurance programmes to cover medical expenses.